Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0471 Transporter Info | ||||
Gene Name | SLC7A5 | ||||
Transporter Name | L-type amino acid transporter 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class 1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 6 TF(s) Regulating This DT |
|||||
ATF2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [1] | ||||
TF Protein Name |
Cyclic AMP-dependent transcription factor ATF-2 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-dependent transcription factor ATF-2 (ATF2) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
ATF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC7A5 gene in prostate cancer condition | [2] | ||||
TF Protein Name |
Cyclic AMP-dependent transcription factor ATF-4 | Transcription Factor Info | ||||
Studied Phenotype |
Prostate cancer [ICD11: 2C82] | |||||
Tissue |
Prostate | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human prostate carcinoma cells (LNCaP-FGC) | |||||
Detailed Description |
Cyclic AMP-dependent transcription factor ATF-4 (ATF4) has been reported to activate the transcription of SLC7A5 gene in prostate cancer condition, which leads to an increased expression of the drug transporter L-type amino acid transporter 1. | |||||
BATF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [3] | ||||
TF Protein Name |
Basic leucine zipper transcriptional factor ATF-like | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Basic leucine zipper transcriptional factor ATF-like (BATF) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
CREB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [3] | ||||
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
Tissue |
Embryo; Liver; Lung; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
JUND |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [1] | ||||
TF Protein Name |
Transcription factor JunD | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Brain; Colon; Coronary artery; Embryo; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor JunD (JUND) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
NFE2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [4] | ||||
TF Protein Name |
Transcription factor NF-E2 45 kDa subunit | Transcription Factor Info | ||||
Tissue |
Blood; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor NF-E2 45 kDa subunit (NFE2) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
Class 1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 11 TF(s) Regulating This DT |
|||||
AHR |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC7A5 gene in breast cancer condition | [5] | ||||
TF Protein Name |
Aryl hydrocarbon receptor | Transcription Factor Info | ||||
Studied Phenotype |
Breast cancer [ICD11: 2C60-2C6Z] | |||||
Tissue |
Breast | |||||
Related DT Changes |
up regulating | |||||
Experimental Material |
Human breast cancer cells (MDA-MB-231); human breast cancer cells (MDA-MB-231) | |||||
Detailed Description |
Aryl hydrocarbon receptor (AHR), influenced by the exogenous polychlorinated dibenzodioxin, has been reported to activate the transcription of SLC7A5 gene in breast cancer condition , which leads to an increased expression of the drug transporter L-type amino acid transporter 1. | |||||
BHLHE40 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [6] | ||||
TF Protein Name |
Class E basic helix-loop-helix protein 40 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Class E basic helix-loop-helix protein 40 (BHLHE40) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
EPAS1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC7A5 gene in brain neuroblastoma condition | [7] | ||||
TF Protein Name |
Endothelial PAS domain-containing protein 1 | Transcription Factor Info | ||||
Studied Phenotype |
Brain neuroblastoma [ICD11: 2A00.11] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Mouse neuroblastoma cells (neuro-2a) | |||||
Detailed Description |
Endothelial PAS domain-containing protein 1 (EPAS1) has been reported to activate the transcription of SLC7A5 gene in brain neuroblastoma condition, which leads to an increased expression of the drug transporter L-type amino acid transporter 1. | |||||
HAND1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [4] | ||||
TF Protein Name |
Heart- and neural crest derivatives-expressed protein 1 | Transcription Factor Info | ||||
Tissue |
Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Heart- and neural crest derivatives-expressed protein 1 (HAND1) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
MNT |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [3] | ||||
TF Protein Name |
Max-binding protein MNT | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Max-binding protein MNT (MNT) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
MXI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [6] | ||||
TF Protein Name |
Max-interacting protein 1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Brain; Cervix; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Max-interacting protein 1 (MXI1) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
MYC |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC7A5 gene in colon cancer condition | [8] | ||||
TF Protein Name |
Myc proto-oncogene protein | Transcription Factor Info | ||||
Affected Drug/Substrate |
Tryptophan | |||||
Studied Phenotype |
Colon cancer [ICD11: 2B90] | |||||
Tissue |
Colon | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
human colon cancer cell isolates | |||||
Detailed Description |
Myc proto-oncogene protein (MYC) has been reported to activate the transcription of SLC7A5 gene in colon cancer condition, which leads to an increased expression of the drug transporter L-type amino acid transporter 1. | |||||
Transcriptional Phenomenon 2 |
Activation of SLC7A5 gene in brain neuroblastoma condition | [9] | ||||
TF Protein Name |
Myc proto-oncogene protein | Transcription Factor Info | ||||
Studied Phenotype |
Brain neuroblastoma [ICD11: 2A00.11] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
human neuroblastoma cell isolates | |||||
Detailed Description |
Myc proto-oncogene protein (MYC) has been reported to activate the transcription of SLC7A5 gene in brain neuroblastoma condition, which leads to an increased expression of the drug transporter L-type amino acid transporter 1. | |||||
TCF12 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [1] | ||||
TF Protein Name |
Transcription factor 12 | Transcription Factor Info | ||||
Tissue |
Blood; Brain; Breast; Lung; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor 12 (TCF12) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
TCF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [3] | ||||
TF Protein Name |
Transcription factor E2-alpha | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2-alpha (TCF3) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
USF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [6] | ||||
TF Protein Name |
Upstream stimulatory factor 1 | Transcription Factor Info | ||||
Tissue |
Brain; Liver; Lung; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Upstream stimulatory factor 1 (USF1) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
USF2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [4] | ||||
TF Protein Name |
Upstream stimulatory factor 2 | Transcription Factor Info | ||||
Tissue |
Cervix; Embryo; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Upstream stimulatory factor 2 (USF2) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
Class 2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
PPARG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC7A5 gene in health condition | [10] | ||||
TF Protein Name |
Peroxisome proliferator-activated receptor gamma | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Placenta | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
human primary placental trophoblast cell isolates | |||||
Detailed Description |
Peroxisome proliferator-activated receptor gamma (PPARG) has been reported to activate the transcription of SLC7A5 gene in health condition, which leads to an increased expression of the drug transporter L-type amino acid transporter 1. | |||||
Class 2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
GATA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [3] | ||||
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Liver; Umbilical cord blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Erythroid transcription factor (GATA1) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
GATA3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [6] | ||||
TF Protein Name |
Trans-acting T-cell-specific transcription factor GATA-3 | Transcription Factor Info | ||||
Tissue |
Blood; Brain; Breast; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Trans-acting T-cell-specific transcription factor GATA-3 (GATA3) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
Class 2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 12 TF(s) Regulating This DT |
|||||
BCL11A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [1] | ||||
TF Protein Name |
B-cell lymphoma/leukemia 11A | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
B-cell lymphoma/leukemia 11A (BCL11A) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
CTCF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [4] | ||||
TF Protein Name |
Transcriptional repressor CTCF | Transcription Factor Info | ||||
Tissue |
Brain | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional repressor CTCF (CTCF) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
EGR1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [1] | ||||
TF Protein Name |
Early growth response protein 1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Breast; Colon; Embryo; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Early growth response protein 1 (EGR1) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
KLF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [4] | ||||
TF Protein Name |
Krueppel-like factor 1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 1 (KLF1) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
KLF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [1] | ||||
TF Protein Name |
Krueppel-like factor 4 | Transcription Factor Info | ||||
Tissue |
Breast; Foreskin; Pancreatic ductal | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 4 (KLF4) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
KLF5 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [3] | ||||
TF Protein Name |
Krueppel-like factor 5 | Transcription Factor Info | ||||
Tissue |
Colon; Pancreatic ductal; Stomach | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 5 (KLF5) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
KLF9 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [6] | ||||
TF Protein Name |
Krueppel-like factor 9 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 9 (KLF9) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [3] | ||||
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Cervix; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
SP4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [6] | ||||
TF Protein Name |
Transcription factor Sp4 | Transcription Factor Info | ||||
Tissue |
Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor Sp4 (SP4) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
ZBTB7A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [4] | ||||
TF Protein Name |
Zinc finger and BTB domain-containing protein 7A | Transcription Factor Info | ||||
Tissue |
Bone marrow; Liver; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger and BTB domain-containing protein 7A (ZBTB7A) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
ZNF217 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [4] | ||||
TF Protein Name |
Zinc finger protein 217 | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger protein 217 (ZNF217) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
ZNF263 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [1] | ||||
TF Protein Name |
Zinc finger protein 263 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Kidney | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger protein 263 (ZNF263) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
Class 3.1: Homeo domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
PBX3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [3] | ||||
TF Protein Name |
Pre-B-cell leukemia transcription factor 3 | Transcription Factor Info | ||||
Tissue |
Blood; Brain; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Pre-B-cell leukemia transcription factor 3 (PBX3) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
POU2F1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [6] | ||||
TF Protein Name |
POU domain, class 2, transcription factor 1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
POU domain, class 2, transcription factor 1 (POU2F1) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
Class 3.2: Paired box factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
PAX5 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [1] | ||||
TF Protein Name |
Paired box protein Pax-5 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Paired box protein Pax-5 (PAX5) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
Class 3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
E2F6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [4] | ||||
TF Protein Name |
Transcription factor E2F6 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Cervix; Embryo; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2F6 (E2F6) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
FOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [6] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Tissue |
Breast; Embryo; Liver; Lung; Pancreatic ductal; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
FOXA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [4] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Tissue |
Embryo; Endoderm; Liver; Lung; Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
FOXP1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [1] | ||||
TF Protein Name |
Forkhead box protein P1 | Transcription Factor Info | ||||
Tissue |
Embryo; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Forkhead box protein P1 (FOXP1) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
Class 3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 7 TF(s) Regulating This DT |
|||||
ERG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [1] | ||||
TF Protein Name |
Transcriptional regulator ERG | Transcription Factor Info | ||||
Tissue |
Aorta | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional regulator ERG (ERG) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
ETS1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [3] | ||||
TF Protein Name |
Protein C-ets-1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone; Bone marrow; Kidney; Lung; Prostate; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Protein C-ets-1 (ETS1) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
FLI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [4] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Mesenchymal; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
GABPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [3] | ||||
TF Protein Name |
GA-binding protein alpha chain | Transcription Factor Info | ||||
Tissue |
Blood; Bone; Bone marrow; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
GA-binding protein alpha chain (GABPA) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
IRF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [1] | ||||
TF Protein Name |
Interferon regulatory factor 1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Pancreatic ductal | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Interferon regulatory factor 1 (IRF1) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
IRF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [6] | ||||
TF Protein Name |
Interferon regulatory factor 4 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Interferon regulatory factor 4 (IRF4) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
MYB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [3] | ||||
TF Protein Name |
Transcriptional activator Myb | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional activator Myb (MYB) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
Class 3.6: TEA domain factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
TEAD1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC7A5 gene in angiogenesis condition | [11] | ||||
TF Protein Name |
Transcriptional enhancer factor TEF-1 | Transcription Factor Info | ||||
Studied Phenotype |
Angiogenesis [ICD11: N.A.] | |||||
Tissue |
Umbilical vein | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human umbilical vein endothelial cell isolates | |||||
Detailed Description |
Transcriptional enhancer factor TEF-1 (TEAD1) has been reported to activate the transcription of SLC7A5 gene in angiogenesis condition, which leads to an increased expression of the drug transporter L-type amino acid transporter 1. | |||||
TEAD2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC7A5 gene in angiogenesis condition | [11] | ||||
TF Protein Name |
Transcriptional enhancer factor TEF-4 | Transcription Factor Info | ||||
Studied Phenotype |
Angiogenesis [ICD11: N.A.] | |||||
Tissue |
Umbilical vein | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human umbilical vein endothelial cell isolates | |||||
Detailed Description |
Transcriptional enhancer factor TEF-4 (TEAD2) has been reported to activate the transcription of SLC7A5 gene in angiogenesis condition, which leads to an increased expression of the drug transporter L-type amino acid transporter 1. | |||||
TEAD4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC7A5 gene in angiogenesis condition | [11] | ||||
TF Protein Name |
Transcriptional enhancer factor TEF-3 | Transcription Factor Info | ||||
Studied Phenotype |
Angiogenesis [ICD11: N.A.] | |||||
Tissue |
Umbilical vein | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human umbilical vein endothelial cell isolates | |||||
Detailed Description |
Transcriptional enhancer factor TEF-3 (TEAD4) has been reported to activate the transcription of SLC7A5 gene in angiogenesis condition, which leads to an increased expression of the drug transporter L-type amino acid transporter 1. | |||||
Class 3.7: ARID domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
ARID3A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [6] | ||||
TF Protein Name |
AT-rich interactive domain-containing protein 3A | Transcription Factor Info | ||||
Tissue |
Bone marrow; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
AT-rich interactive domain-containing protein 3A (ARID3A) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
KDM5B |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [4] | ||||
TF Protein Name |
Lysine-specific demethylase 5B | Transcription Factor Info | ||||
Tissue |
Bone marrow; Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Lysine-specific demethylase 5B (KDM5B) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
TF Superclass 4: Other all-alpha-helical DNA-binding domains |
||||||
Class 4.2: Heteromeric CCAAT-binding factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
NFYB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [3] | ||||
TF Protein Name |
Nuclear transcription factor Y subunit beta | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Nuclear transcription factor Y subunit beta (NFYB) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
Class 6.1: Rel homology region factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
EBF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [4] | ||||
TF Protein Name |
Transcription factor COE1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor COE1 (EBF1) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
RELA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC7A5 gene in lung adenocarcinoma condition | [12] | ||||
TF Protein Name |
Transcription factor p65 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Glutamine | |||||
Studied Phenotype |
Lung adenocarcinoma [ICD11: 2C25.0] | |||||
Tissue |
Lung | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
human lung adenocarcinoma associated fibroblast isolates | |||||
Detailed Description |
Transcription factor p65 (RELA) has been reported to activate the transcription of SLC7A5 gene in lung adenocarcinoma condition, which leads to an increased expression of the drug transporter L-type amino acid transporter 1. | |||||
Class 6.2: STAT domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
STAT5A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC7A5 gene in health condition | [13] | ||||
TF Protein Name |
Signal transducer and activator of transcription 5A | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Breast | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Holstein cows | |||||
Detailed Description |
Signal transducer and activator of transcription 5A (STAT5A) has been reported to activate the transcription of SLC7A5 gene in health condition, which leads to an increased expression of the drug transporter L-type amino acid transporter 1. | |||||
Class 6.7: Grainyhead domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GRHL2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [1] | ||||
TF Protein Name |
Grainyhead-like protein 2 homolog | Transcription Factor Info | ||||
Tissue |
Breast; Bronchus; Ovary; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Grainyhead-like protein 2 homolog (GRHL2) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
TF Superclass 7: beta-Hairpin exposed by an alpha/beta-scaffold |
||||||
Class 7.1: SMAD/NF-1 DNA-binding domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
NFIC |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [6] | ||||
TF Protein Name |
Nuclear factor 1 C-type | Transcription Factor Info | ||||
Tissue |
Blood; Liver; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Nuclear factor 1 C-type (NFIC) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
Class 9.1: Cold-shock domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
YBX3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC7A5 gene in cervical cancer condition | [14] | ||||
TF Protein Name |
Y-box-binding protein 3 | Transcription Factor Info | ||||
Studied Phenotype |
Cervical cancer [ICD11: 2C77] | |||||
Tissue |
Cervix | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human human papillomavirus-related endocervical adenocarcinoma cells (HeLa) | |||||
Detailed Description |
Y-box-binding protein 3 (YBX3) has been reported to activate the transcription of SLC7A5 gene in cervical cancer condition, which leads to an increased expression of the drug transporter L-type amino acid transporter 1. | |||||
Class 10: Uncharacterized |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
NRF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC7A5 gene | [6] | ||||
TF Protein Name |
Nuclear respiratory factor 1 | Transcription Factor Info | ||||
Tissue |
Brain; Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Nuclear respiratory factor 1 (NRF1) can directly bind to the SLC7A5 gene, which in turn affects the expression or function of the drug transporter L-type amino acid transporter 1. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.